Cannae (CNNE) director granted 23,453 restricted shares; holds 62,356
Cannae Holdings (CNNE) reported a director equity grant on a Form 4.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cannae Holdings (CNNE) reported a director equity grant on a Form 4. On 11/12/2025, the reporting person acquired 23,453 shares of common stock at $0, identified as a grant of restricted stock.
Following the transaction, the director beneficially owns 62,356 shares, held directly. The grant vests in three equal annual installments beginning November 12, 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 23,453 | $0.00 | $0.00 |
Footnotes (1)
- F1. Grant of restricted stock vesting in three equal annual installments beginning November 12, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Cannae (CNNE) disclose on this Form 4?
What is the vesting schedule for the CNNE restricted stock grant?
What was the transaction price for the CNNE grant?
What is the relationship of the reporting person to Cannae (CNNE)?
Was this Form 4 filed for one or multiple reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.